ArticlePloS one2026
Equity in the allocation of oncology bed resources in China: Longitudinal data from 2008 to 2022.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCancer has emerged as one of the most significant public health challenges in the 21st century. With rapidly growing demand for oncology services, the allocation of oncology bed resources is closely associated with the accessibility and effectiveness of cancer diagnosis and treatment. This study presents a comprehensive assessment of equity in oncology bed allocation across Chinese hospitals, providing evidence to inform policy decisions for optimizing cancer care resource distribution.
methodsData were extracted from the China Health Statistics Yearbook (2007-2023), and analyzed using Lorenz curves, Gini coefficients(G), and Theil index (T) to evaluate the equity of oncology bed resource allocation in China.
resultsFrom 2008 to 2022, the number of oncology beds in Chinese hospitals showed an increasing trend, but the growth rate slowed down. According to Lorenz curves, the equity of oncology bed allocation by population was better than by geographic area. Compared to 2008, the population-based equity improved in 2022, while the geographic area-based equity showed no improvement. Based on G, the population-based allocation of oncology beds from 2008 to 2022 had G between 0.15 and 0.20, indicating absolute equity with an overall declining trend, while the geographic area-based allocation maintained G around 0.69, consistently showing severe inequity. According to T, population-based allocation demonstrated better equity with T all below 0.1, whereas geographic area-based allocation showed poorer equity with indices all above 0.6. For both population and geographic dimensions, within-group T were greater than between-group indices, indicating that inequity primarily stemmed from intra-regional disparities.
conclusionWhile China's oncology bed resources are expanding in scale, they are facing dual challenges of imbalanced "population-geography" allocation and significant regional differences. We should focus on improving geographical accessibility and regional balance to help alleviate the 'difficulty in hospitalization' for cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.